FAS and hyperlipidemia: Furthermore, both in vitro and in vivo experiments showed that IPA significantly diminished OA- and HFD-induced lipid elevation accompanied by the reduced transcription of SREBP1c and FAS, thus corroborating the notion that IPA functions as the key microbial metabolite responsible for the protective role of DNJ on hyperlipidemia.